Met Life Investment Management, LLC Ptc Therapeutics, Inc. Transaction History

Met Life Investment Management, LLC

$17.1 Billion
Q3 2024

A detailed history of Met Life Investment Management, LLC transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 44,007 shares of PTCT stock, worth $2 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

44,007

Previous 44,007 -0.0%

Holding current value

$2 Million

Previous $1.35 Million 21.34%

% of portfolio

0.01%

Previous 0.01%

51 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$24.69 - $40.12 $168,558 - $273,899	6,827 Added 18.36%	44,007 $1.35 Million
Q1 2024 May 14, 2024	BUY	$24.15 - $31.95 $897,897 - $1.19 Million	37,180 New	37,180 $1.08 Million
Q2 2023 Apr 29, 2024	BUY	$40.4 - $59.1 $1.5 Million - $2.2 Million	37,180 New	37,180 $1.51 Million
Q1 2023 May 09, 2024	BUY	$38.16 - $48.86 $1.42 Million - $1.82 Million	37,180 New	37,180 $1.8 Billion
Q3 2022 May 10, 2024	BUY	$41.85 - $53.85 $11,550 - $14,862	276 Added 0.75%	37,180 $1.87 Million
Q3 2022 Mar 22, 2023	BUY	$41.85 - $53.85 $11,550 - $14,862	276 Added 0.75%	37,180 $1.87 Million
Q3 2022 Nov 14, 2022	BUY	$41.85 - $53.85 $11,550 - $14,862	276 Added 0.75%	37,180 $1.87 Million
Q2 2022 May 10, 2024	SELL	$25.6 - $45.23 $39,296 - $69,428	-1,535 Reduced 3.99%	36,904 $1.48 Million
Q2 2022 Jun 20, 2023	SELL	$25.6 - $45.23 $7,065 - $12,483	-276 Reduced 0.74%	36,904 $1.48 Million
Q2 2022 Mar 22, 2023	SELL	$25.6 - $45.23 $39,296 - $69,428	-1,535 Reduced 3.99%	36,904 $1.48 Million
Q2 2022 Aug 11, 2022	SELL	$25.6 - $45.23 $39,296 - $69,428	-1,535 Reduced 3.99%	36,904 $1.48 Million
Q1 2022 May 10, 2024	BUY	$33.33 - $44.6 $1.28 Million - $1.71 Million	38,439 New	38,439 $1.43 Million
Q1 2022 Jun 20, 2023	BUY	$33.33 - $44.6 $41,962 - $56,151	1,259 Added 3.39%	38,439 $1.43 Million
Q1 2022 Mar 22, 2023	BUY	$33.33 - $44.6 $448,221 - $599,780	13,448 Added 53.81%	38,439 $1.43 Million
Q1 2022 May 12, 2022	BUY	$33.33 - $44.6 $448,221 - $599,780	13,448 Added 53.81%	38,439 $1.43 Million
Q4 2021 Jun 21, 2023	SELL	$35.36 - $41.86 $431,003 - $510,231	-12,189 Reduced 32.78%	24,991 $995,000
Q3 2021 Jun 21, 2023	SELL	$37.01 - $44.74 $451,114 - $545,335	-12,189 Reduced 32.78%	24,991 $929,000
Q2 2021 May 17, 2024	BUY	$37.95 - $49.37 $56,052 - $72,919	1,477 Added 6.28%	24,991 $1.06 Million
Q2 2021 Jun 21, 2023	SELL	$37.95 - $49.37 $462,572 - $601,770	-12,189 Reduced 32.78%	24,991 $1.06 Million
Q2 2021 Mar 22, 2023	BUY	$37.95 - $49.37 $56,052 - $72,919	1,477 Added 6.28%	24,991 $1.06 Million
Q2 2021 Aug 16, 2021	BUY	$37.95 - $49.37 $56,052 - $72,919	1,477 Added 6.28%	24,991 $1.06 Million
Q1 2021 May 17, 2024	SELL	$46.8 - $68.92 $639,568 - $941,860	-13,666 Reduced 36.76%	23,514 $1.11 Million
Q1 2021 Jun 26, 2023	SELL	$46.8 - $68.92 $639,568 - $941,860	-13,666 Reduced 36.76%	23,514 $1.11 Billion
Q1 2021 Mar 22, 2023	SELL	$46.8 - $68.92 $96,127 - $141,561	-2,054 Reduced 8.03%	23,514 $1.11 Million
Q1 2021 May 14, 2021	SELL	$46.8 - $68.92 $96,127 - $141,561	-2,054 Reduced 8.03%	23,514 $1.11 Million
Q4 2020 May 24, 2024	SELL	$47.96 - $67.64 $81,436 - $114,852	-1,698 Reduced 6.23%	25,568 $1.56 Million
Q4 2020 Jun 22, 2023	SELL	$47.96 - $67.64 $556,911 - $785,435	-11,612 Reduced 31.23%	25,568 $1.56 Million
Q4 2020 Mar 22, 2023	SELL	$47.96 - $67.64 $81,436 - $114,852	-1,698 Reduced 6.23%	25,568 $1.56 Million
Q4 2020 Feb 16, 2021	SELL	$47.96 - $67.64 $81,436 - $114,852	-1,698 Reduced 6.23%	25,568 $1.56 Million
Q3 2020 Jun 26, 2023	SELL	$45.41 - $57.07 $450,194 - $565,791	-9,914 Reduced 26.66%	27,266 $1.27 Million
Q2 2020 May 24, 2024	SELL	$42.56 - $54.98 $421,939 - $545,071	-9,914 Reduced 26.66%	27,266 $1.38 Billion
Q2 2020 Jun 26, 2023	SELL	$42.56 - $54.98 $421,939 - $545,071	-9,914 Reduced 26.66%	27,266 $1.38 Million
Q2 2020 Mar 22, 2023	BUY	$42.56 - $54.98 $62,733 - $81,040	1,474 Added 5.71%	27,266 $1.38 Million
Q2 2020 Aug 14, 2020	BUY	$42.56 - $54.98 $62,733 - $81,040	1,474 Added 5.71%	27,266 $1.38 Million
Q1 2020 Jul 12, 2023	SELL	$32.37 - $59.36 $368,629 - $675,991	-11,388 Reduced 30.63%	25,792 $1.15 Million
Q4 2019 Jul 12, 2023	SELL	$32.22 - $50.07 $366,921 - $570,197	-11,388 Reduced 30.63%	25,792 $1.24 Million
Q3 2019 Jul 12, 2023	SELL	$33.82 - $48.17 $385,142 - $548,559	-11,388 Reduced 30.63%	25,792 $872,000
Q3 2019 Mar 22, 2023	BUY	$33.82 - $48.17 $98,585 - $140,415	2,915 Added 12.74%	25,792 $872,000
Q3 2019 Nov 14, 2019	BUY	$33.82 - $48.17 $98,585 - $140,415	2,915 Added 12.74%	25,792 $872,000
Q2 2019 Jul 12, 2023	SELL	$35.42 - $45.0 $403,362 - $512,460	-11,388 Reduced 30.63%	25,792 $1.16 Million
Q1 2019 Jul 13, 2023	SELL	$28.09 - $39.49 $401,771 - $564,825	-14,303 Reduced 38.47%	22,877 $861,000
Q1 2019 Mar 22, 2023	BUY	$28.09 - $39.49 $51,320 - $72,148	1,827 Added 8.68%	22,877 $861,000
Q1 2019 May 15, 2019	BUY	$28.09 - $39.49 $51,320 - $72,148	1,827 Added 8.68%	22,877 $861,000
Q4 2018 Jul 13, 2023	SELL	$29.83 - $46.51 $481,157 - $750,206	-16,130 Reduced 43.38%	21,050 $722,000
Q4 2018 Mar 22, 2023	SELL	$29.83 - $46.51 $346,326 - $539,981	-11,610 Reduced 35.55%	21,050 $722,000
Q4 2018 Feb 14, 2019	SELL	$29.83 - $46.51 $346,326 - $539,981	-11,610 Reduced 35.55%	21,050 $722,000
Q3 2018 Jul 13, 2023	SELL	$33.9 - $47.77 $546,807 - $770,530	-16,130 Reduced 43.38%	21,050 $989,000
Q3 2018 Mar 22, 2023	SELL	$33.9 - $47.77 $153,228 - $215,920	-4,520 Reduced 12.16%	32,660 $1.54 Million
Q3 2018 Nov 14, 2018	BUY	$33.9 - $47.77 $393,579 - $554,609	11,610 Added 55.15%	32,660 $1.54 Million
Q2 2018 Aug 15, 2018	BUY	$25.7 - $47.88 $47,545 - $88,578	1,850 Added 9.64%	21,050 $710,000
Q4 2017 Feb 15, 2018	BUY	$15.14 - $20.89 $290,688 - $401,088	19,200	19,200 $320,000

Others Institutions Holding PTCT

# of Institutions

221

Shares Held

78.1M

Call Options Held

144K

Put Options Held

58.7K

View Full List

About PTC THERAPEUTICS, INC.

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.24B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

More about PTCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Account

Met Life Investment Management, LLC Ptc Therapeutics, Inc. Transaction History